Efficacy and safety of lobeglitazone, a new Thiazolidinedione, as compared to the standard of care in type 2 diabetes mellitus: A systematic review and meta-analysis.

Add to Collection

2023 Jan Systematic Review and Meta Analysis SR Joshi, S Das, S Xaviar, SS Samajdar, I Saha… - Diabetes & Metabolic …, 2023 - Elsevier 152

Full Author : ['Joshi, Shashank R', 'Das, Saibal', 'Xaviar, Suja', 'Samajdar, Shambo Samrat', 'Saha, Indranil', 'Sarkar, Sougata', 'Mukherjee, Shatavisa', 'Tripathi, Santanu Kumar', 'Pal, Jyotirmoy', 'Chatterjee, Nandini']
Journal Title : Diabetes & metabolic syndrome
Chapter : Section3
Journal Year : 2023
Cited by : 2.0

AIM: This systematic review and meta-analysis was conducted to evaluate the efficacy and safety of lobeglitazone as compared to the standard of care (SOC) in patients with type 2 diabetes mellitus (T2DM). METHODS: Databases were searched for relevant rand..... Read More

Keywords : ["type diabetes mellitus", "systematic review", "new thiazolidinedione", "standard", "safety", "metaanalysis", "lobeglitazone", "efficacy", "compare", "care"]
PubMed Link : https://www.sciencedirect.com/science/article/pii/S1871402122003204
Google Scholar Link : https://scholar.google.com/scholar?cites=16250182337381197435&as_sdt=2005&sciodt=0,5&hl=en&num=20

Have a Question?

Efficacy and safety of lobeglitazone, a new Thiazolidinedione, as compared to the standard of care in type 2 diabetes mellitus: A systematic review and meta-analysis.